Sugi Predict

Sugi Predict / Targets / HNRNPC

HNRNPC

Heterogeneous nuclear ribonucleoproteins C1/C2 · P07910 · HNRNPC on Sugi Atlas →

0 patent compounds predicted against HNRNPC, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPC by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Identification of New FTLD Genes nanUNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
International PPB/DICER1 Registry nanRECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a HNRNPC binder may also engage these)

ProteinNameSimilarity
Q9Z204 — 1.000 Q9Z204 →
Q5RA82 — 1.000 Q5RA82 →
O77768 — 1.000 O77768 →
Q08DJ0 — 0.994 Q08DJ0 →
G3V9R8 — 0.993 G3V9R8 →
Q86SE5 — 0.987 Q86SE5 →
Q8BTF8 — 0.986 Q8BTF8 →
Q0VFL7 — 0.985 Q0VFL7 →
P19600 — 0.976 P19600 →
B2RXH8 — 0.975 B2RXH8 →
Q64012 — 0.967 Q64012 →
O60812 — 0.965 O60812 →
B7ZW38 — 0.962 B7ZW38 →
P0DMR1 — 0.962 P0DMR1 →
Q9UKM9 — 0.961 Q9UKM9 →
P97855 — 0.956 P97855 →
Q5R9L3 — 0.954 Q5R9L3 →
Q794E4 — 0.953 Q794E4 →
Q9HA38 — 0.952 Q9HA38 →
Q0IIC4 — 0.951 Q0IIC4 →
Q5RB87 — 0.950 Q5RB87 →
Q32LC7 — 0.950 Q32LC7 →
Q9WU01 — 0.949 Q9WU01 →
G3BP1 Ras GTPase-activating protein-binding protein 1 0.949 landscape →
G3BP2 Ras GTPase-activating protein-binding protein 2 0.948 landscape →
Q8N108 — 0.948 Q8N108 →
Q56A18 — 0.948 Q56A18 →
Q5REE1 — 0.947 Q5REE1 →
Q8BGD9 — 0.947 Q8BGD9 →
EIF4B Eukaryotic translation initiation factor 4B 0.946 landscape →